COMET's path, and the new biologicals in rheumatoid arthritis

Lancet. 2008 Aug 2;372(9636):347-8. doi: 10.1016/S0140-6736(08)61001-6. Epub 2008 Jul 16.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antirheumatic Agents / administration & dosage
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / diagnostic imaging
  • Arthritis, Rheumatoid / drug therapy*
  • Biological Therapy / trends*
  • Double-Blind Method
  • Drug Therapy, Combination
  • Etanercept
  • Humans
  • Immunoglobulin G / administration & dosage
  • Immunoglobulin G / therapeutic use*
  • Methotrexate / administration & dosage
  • Methotrexate / therapeutic use*
  • Radiography
  • Randomized Controlled Trials as Topic*
  • Receptors, Tumor Necrosis Factor / administration & dosage
  • Receptors, Tumor Necrosis Factor / therapeutic use*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antirheumatic Agents
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Etanercept
  • Methotrexate